Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-26T22:17:52.786Z Has data issue: false hasContentIssue false
  • English
  • Français

Reviews in Health Law: Patenting Technology Instead of Identity

Published online by Cambridge University Press:  01 January 2021

Kelly McPherson Jolley
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
JLME Column
Information
Journal of Law, Medicine & Ethics , Volume 32 , Issue 3 , Fall 2004 , pp. 524 - 527
Copyright
Copyright © American Society of Law, Medicine and Ethics 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Diamond v. Chakraberty, 447 U.S. 303.Google Scholar
Grisham, J., “New Rules for Gene Patents” Nature Biotechnology 18, no. 9 (2000): at 921; Gitter, D.M., “International Conflicts Over Patenting Human DNA Sequences in the United State and the European Union: An Argument for Compulsory Licensing and a Fair-Use Exemption,” New York University Law Review 76 (2001): at 1624; Pollack, A., “U.S. Hopes to Stem Rush Toward Patenting Genes,” The Patriot Ledger (Quincy, MA), June 29, 2002: at 18.Google Scholar
Grisham, , supra note 2, at 921.Google Scholar
Grisham, , supra note 2, at 921.Google Scholar
Grisham, , supra note 2, at 50.Google Scholar
Resnik, D. B., Owning the Human Genome; A Moral Analysis of DNA Patenting (Albany, NY: SUNY Press, 2004): at 51.Google Scholar
Resnik, , supra note 6, at 51.Google Scholar
Resnik, , supra note 6, at 155.Google Scholar
Resnik, , supra note 6, at 66.Google Scholar
Resnik, , supra note 6, at 66, 72.Google Scholar
Resnik, , supra note 6, at 67.Google Scholar
Resnik, , supra note 6, at 67.Google Scholar
Frankena, W., Ethics, 2nd ed. (Englewood Cliffs, NJ: Prentice-Hall, 1973).Google Scholar
Resnik, , supra note 6, at 73.Google Scholar
Resnik, , supra note 6, at 77.Google Scholar
Resnik, , supra note 6, at 78.Google Scholar
Resnik, , supra note 6,. at 78.Google Scholar
Resnik, , supra note 6,. at 81.Google Scholar
Resnik, , supra note 6, at 80.Google Scholar
Resnik, D. B., “DNA Patents and Human Dignity” Journal of Law, Medicine & Ethics 29, no. 2 (2001): 152–65.CrossRefGoogle Scholar
Resnik, , supra note 6, at 129.Google Scholar
Resnik, , supra note 6, at 196Google Scholar
Resnik, , supra note 6, at 196.Google Scholar
Resnik, , supra note 6, at 196.Google Scholar
Resnik, , supra note 6,. at 201.Google Scholar
Resnik, , supra note 6,. at 65.Google Scholar
Resnik, , supra note 6, at 65.Google Scholar
Resnik, , supra note 6, at 83–84.Google Scholar
Resnik, , supra note 6, at 197.Google Scholar
Resnik, , supra note 6, at 197.Google Scholar
Resnik, , supra note 6, at 200.Google Scholar
See, e.g., Pitcher, A.S., “Contrary to First Impression, Genes are Patentable: Should there be Limitations?” Journal of Health Care Law and Policy 6 (2003): at 284; Horn, M. E., “DNA Patenting and Access to Healthcare: Achieving the Balance Among Competing Interests,” Cleveland State Law Review 50 (2003): at 253; Lissy, N. A., “Patentability of Chemical and Biotechnology Inventions: A Discrepancy in Standards,” Washington University Law Quarterly 81 (2003): at 1069.Google Scholar